IL6 and metabolic disease: This dysfunction promotes metabolic disorders via a mild, chronic inflammation which is characterized by an increased expression of pro-inflammatory factors such as leptin, TNFα, IL6 or monocyte chemoattractant protein-1 (MCP-1 — also known as CCL2) (55).